| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/14/2001 | CA2124083C Preparation of substituted piperidines |
| 08/14/2001 | CA2014545C Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057222A1 A protease, a gene therefor and the use thereof |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057075A2 Virulence genes, proteins, and their use |
| 08/09/2001 | WO2001057070A1 Melanin-concentrating hormone analogs |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057039A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001056996A1 Hydantoin c-proteinase inhibitors |
| 08/09/2001 | WO2001056993A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001056578A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs) |
| 08/09/2001 | WO2001056573A1 Use of cox-2 inhibitors as gastroprokinetics |
| 08/09/2001 | WO2001056569A1 Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001056568A1 Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001056555A2 Use of cox-2 inhibitors for the treatment of constipation |
| 08/09/2001 | WO2001056547A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 08/09/2001 | WO2001056406A1 Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 08/09/2001 | WO2001056405A2 A method for maintaining or improving the synthesis of mucins |
| 08/09/2001 | WO2001056404A1 Low molecular weight polymannuronate |
| 08/09/2001 | WO2001019814A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 08/09/2001 | WO2001016312A3 Nucleic acid based modulators of gene expression |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2000076452A3 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000069257A3 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 08/09/2001 | WO2000066094A3 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents |
| 08/09/2001 | WO2000045795A3 Topical sprays comprising a film forming composition |
| 08/09/2001 | WO2000005224A3 Heterocyclic derivatives and their use as integrin inhibitor |
| 08/09/2001 | US20010013134 Transgenic mammal; polynucleotide containing pancreas promoter |
| 08/09/2001 | US20010012895 Therapy for hair loss in mammals; drug resistance; nervous system disorders |
| 08/09/2001 | US20010012856 Compositions and methods for the treatment of anorectal disorders |
| 08/09/2001 | US20010012845 Adminstering an E-type prostaglandin ligand and a cyclooxygenase-2 enzyme selective inhibitor compound in combination with a carrier to treat inflammation |
| 08/09/2001 | US20010012837 Anti-ulcer composition |
| 08/09/2001 | US20010012629 Given grampositive bacteria strains with reduced 7alpha-dehydroxylase activity and reduced rate of bile acid deconjugation; treating biliary dyspepsia, cholelithiasis, hepatopathies, inflammation of the colon |
| 08/09/2001 | US20010012512 Non-virulent porphyromonas gingivalis mutant |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399545A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor |
| 08/09/2001 | CA2399509A1 Melanin-concentrating hormone analogs |
| 08/09/2001 | CA2399063A1 A method for maintaining or improving the synthesis of mucins |
| 08/09/2001 | CA2398996A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | CA2396197A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs) |
| 08/09/2001 | CA2369076A1 Pyrazole compositions useful as inhibitors of erk |
| 08/08/2001 | EP1122257A1 Benzimidazole compounds as ORL1-receptor agonists |
| 08/08/2001 | EP1122243A1 Novel imidazoles with anti-inflammatory activity |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121420A2 Hepatitis a vaccines |
| 08/08/2001 | EP1121372A1 Adenine derivatives |
| 08/08/2001 | EP1121360A1 Il-8 receptor antagonists |
| 08/08/2001 | EP1121349A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | EP1121133A1 Methods for stimulating bone formation |
| 08/08/2001 | EP1121113A1 Methods for regulating bone formation |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | EP1121107A2 Sertraline oral concentrate |
| 08/08/2001 | EP1121106A1 Treatment of dyspepsia |
| 08/08/2001 | EP1121103A2 Orally disintegrable tablets |
| 08/08/2001 | EP1121099A1 Pharmaceutical composition with gastric residence and controlled release |
| 08/08/2001 | EP1121064A1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 08/08/2001 | EP0965342B1 Preparation for percutaneous administration containing 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazole |
| 08/08/2001 | EP0960118A4 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 08/08/2001 | EP0824357B1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 08/08/2001 | CN1307632A Ependymal neural stem cells and method for their isolation |
| 08/08/2001 | CN1307577A Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 08/08/2001 | CN1307567A 1,5 benzodiazepine derivatives |
| 08/08/2001 | CN1307561A Novel VLA-4 inhibitor: oMePUPA-V |
| 08/08/2001 | CN1307482A Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/08/2001 | CN1307477A Method and composition for treatment of inflammatory conditions |
| 08/08/2001 | CN1307471A Use of NMDA antagonists for treatment of irritable bowel syndrome |
| 08/08/2001 | CN1307061A Praparation of anticaries bacteria IgY, and anticaries composition |
| 08/08/2001 | CN1306854A Water extracted and alcohol precipitated matter of subprostrate sophora and its application in medicine |
| 08/08/2001 | CN1306851A Chinese medicine preparation for treating toothache |
| 08/08/2001 | CN1306846A Chinese medicine preparation for treating precancerous lesion of atrophic gastritis |
| 08/08/2001 | CN1306844A Catharsis granule |
| 08/08/2001 | CN1306839A Notoginseng flower capsule |
| 08/08/2001 | CN1306817A Antiseptic caries-preventing chewing gum |
| 08/08/2001 | CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/08/2001 | CN1069211C Gastrosis plaster |
| 08/08/2001 | CN1069200C Medicine made from plum and apricot and production method thereof |
| 08/08/2001 | CN1069198C Oral liquid for strengthening liver and preparating process thereof |
| 08/07/2001 | US6271365 Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them |
| 08/07/2001 | US6271262 Metalloproteinase inhibitors |
| 08/07/2001 | US6271261 Chemokine mediated diseases, binding interleukins or beta-receptors and administering to mammals |
| 08/07/2001 | US6271257 Decreasing the intracellular level of β-catenin by administering hydroxymatairesinol |
| 08/07/2001 | US6271252 Cyclic amino acid derivatives as cell adhesion inhibitors |